florbetapir F 18

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Evaluation of Reader Training Processes

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Evaluation of PET Scan Timing Relative to AV-45 Injection Time

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers